Susquehanna International Group, LLP My Md Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$0.22 - $0.58 $17,996 - $47,444	-81,800 Reduced 74.23%	28,400 $7,000
Q3 2023 Nov 14, 2023	BUY	$0.47 - $1.87 $10,716 - $42,636	22,800 Added 26.09%	110,200 $65,000
Q2 2023 Aug 11, 2023	BUY	$1.44 - $2.26 $66,960 - $105,089	46,500 Added 113.69%	87,400 $131,000
Q1 2023 May 16, 2023	BUY	$1.1 - $2.86 $44,990 - $116,974	40,900 New	40,900 $70,000
Q3 2022 Nov 14, 2022	BUY	$2.22 - $82.2 $38,184 - $1.41 Million	17,200 New	17,200 $45,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.